Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance

BackgroundStatins are the most widely prescribed medication to lower low-density lipoprotein cholesterol (LDL-c). However, a significant portion of patients are unable to tolerate them due to side effects, most commonly muscle related. Nutraceuticals, natural plant derivatives with lipid-lowering pr...

Full description

Bibliographic Details
Main Authors: Natalie C. Ward, Christopher M. Reid, Gerald F. Watts
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
statin intolerance
nutraceuticals
ezetimibe
low-density lipoprotein (LDL)
lipids
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1060252/full

Similar Items

Similar Items